Anavo Therapeutics BV Alternatives & Competitors

12 companies similar to Anavo Therapeutics BV — UNLOCKING THE PHOSPHATASE TARGET CLASS

ProteinQure

dare to deliver

32 Series A $18.12M

Toronto, Canada

Biotechnology

Paragon Genomics

Your NGS Panel Development and OEM Partner

17 Series A $8.00M

Fremont, United States

Biotechnology Health Care +1

Bruker Biosensors

Bruker Biosensors provides analytical systems for the characterization of biomolecules and...

61 Series A

Munchen, Germany

Biopharma Biotechnology +2

Neurochlore

Understanding and Treating Developmental Brain Disorders

2 Non Equity Assistance

France

Track all Anavo Therapeutics BV competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

MoglingBio Inc

Rejuvenation of stem cells

1 Seed

United States

Health Care

Reaction Biology

Contract research organization with commitment to quality data and quality support. Let's...

146 Acquired

Malvern, United States

Biotechnology Pharmaceutical

PreComb

AI-guided Functional Precision Medicine

11 Series A $3.50M

Hombrechtikon, Switzerlan...

Sibylla Biotech

Fold the future

44 Series A $23.00M

Bresso, Italy

Biotechnology Health Care +1

Minerva Biotechnologies

We see the future first

17 Unknown $61.30M

Waltham, United States

Biotechnology Health Care +1

BEYOND GENOMiX

Proprietary multi-omics platform delivering actionable insights for age-related disease di...

4 Unknown

Neuchatel, Switzerland

AI Biotechnology +1

Oncoheroes Biosciences

Biotech Company 100% Focused on Pediatric Cancer Drug Development

10 Series Unknown $1.10M

Boston, United States

Biotechnology

Frontier Medicines

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...

77 Series C $255.50M

South San Francisco, Unit...

Biopharma Biotechnology +2

About Anavo Therapeutics BV

UNLOCKING THE PHOSPHATASE TARGET CLASS

Services

phosphatase-targeted drug discovery, development of first-in-class therapeutic programs, support for partners’ therapeutic pipelines, proprietary IGNITE platform utilization, biotechnology research and development

Target Customers

pharmaceutical companies, biotech firms, oncology researchers, academic institutions, investors in biotechnology

Taxonomy

Phosphatase Drug Discovery, Allosteric Modulators, Oncology Therapeutics, Therapeutic Programs Development, First-in-Class Drugs, Phosphatase-driven Disease Biology, Biopharmaceuticals, Drug Target Space, Biotechnology Innovation, Platform Partnerships, Pipeline Development, Venture-backed Biotech, Disease Biology Expertise

Business Model

B2B, D2C, B2B2B

Revenue Model

Licensing, Service Fee

Frequently Asked Questions

Top alternatives to Anavo Therapeutics BV include ProteinQure, Paragon Genomics, Bruker Biosensors, Neurochlore, MoglingBio Inc. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Anavo Therapeutics BV based on industry overlap, target customers, and business model.

UNLOCKING THE PHOSPHATASE TARGET CLASS

Don't just read about them. Follow them.

BounceWatch watches Anavo Therapeutics BV and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Anavo Therapeutics BV Profile ProteinQure Alternatives Paragon Genomics Alternatives Bruker Biosensors Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Anavo Therapeutics BV on 2 Apr 2026. The 12 companies listed here were last checked between 23 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.